It’s an exciting week ahead for pharmaceutical companies Relypsa Inc (NASDAQ:RLYP), GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Exelixis, Inc. (NASDAQ:EXEL), as …
Analysts weigh in on biotech companies Celgene Corporation (NASDAQ:CELG) and Relypsa Inc (NASDAQ:RLYP). While one analyst is bullish on Celgene ahead of earnings, …
Healthcare analysts weighed in on pharmaceutical companies Sarepta Therapeutics (NASDAQ:SRPT), and Relypsa Inc (NASDAQ:RLYP). With Sarepta approaching an FDA advisory committee meeting, and Relypsa facing an issue regarding …
Linn Energy LLC (NASDAQ:LINE) is down 16% in pre-market trading due to falling oil prices resulting from yesterday’s world oil producers meeting in Doha, …
Facebook Inc Facebook Inc (NASDAQ:FB) has added some new features to its Facebook Live to give people “more ways to discover, share, and interact …
The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among …
Healthcare analysts weigh in on drug makers Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as one explores potential sale and the other gets closer to FDA …
Both biopharmaceutical companies Relypsa Inc (NASDAQ:RLYP) and Pernix Therapeutics Holdings Inc (NASDAQ:PTX) run into obstacles amidst preparing for the launch of their pipeline …
Healthcare analysts provide insight into Relypsa Inc (NASDAQ:RLYP) and Aduro BioTech Inc (NASDAQ:ADRO) as Relypsa begins commercialization of Veltassa, a drug to treat hyperkalemia, …
Healthcare analysts explain why they are bullish on biotech firm Relypsa Inc (NASDAQ:RLYP) and vaccine developer Inovio Pharmaceuticals Inc (NASDAQ:INO) regarding drug launch data …
